Akebia Therapeutics
AKBA
$1.14
Share price
1.79%
Change (1 day)
192.31%
Change (1 year)
Categories
Market capitalization of Akebia Therapeutics (AKBA)
Market cap: $0.21 Billion
As of September 2023 Akebia Therapeutics has a market cap of $0.21 Billion. This makes Akebia Therapeutics the world's 6471th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Akebia Therapeutics from 2014 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $0.21 B | 102.25% |
| 2022 | $0.10 B | -73.16% |
| 2021 | $0.39 B | -2.3% |
| 2020 | $0.40 B | -47.37% |
| 2019 | $0.76 B | 18.97% |
| 2018 | $0.64 B | -8.04% |
| 2017 | $0.70 B | 76.18% |
| 2016 | $0.39 B | 0.71% |
| 2015 | $0.39 B | 67.07% |
| 2014 | $0.23 B |
End of Day market cap according to different sources
On Sep 28th, 2023 the market cap of Akebia Therapeutics was reported to be:
$0.21 Billion
$0.21 Billion
$0.21 Billion
$0.20 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $375.54 B | 174,836.04% | 🇺🇸 USA |
 Novartis NVS | $210.72 B | 98,058.50% | 🇨🇭 Switzerland |
 Amgen AMGN | $143.77 B | 66,870.40% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.11 B | -46.24% | 🇺🇸 USA |